Cargando…
Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy
PURPOSE: We aimed to investigate clinical outcomes between top-down (TD) and conventional step-up (SU) therapies in pediatric patients with moderate to severe ulcerative colitis (UC). MATERIALS AND METHODS: All patients underwent clinical and endoscopic evaluation at diagnosis and 4 months and 1 yea...
Autores principales: | Kim, Mi Jin, Kim, Eunsil, Kang, Ben, Choe, Yon Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236348/ https://www.ncbi.nlm.nih.gov/pubmed/34164958 http://dx.doi.org/10.3349/ymj.2021.62.7.608 |
Ejemplares similares
-
Clinical Course of Infliximab Treatment in Korean Pediatric Ulcerative Colitis Patients: A Single Center Experience
por: Kim, Jong Min, et al.
Publicado: (2014) -
Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021) -
Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008) -
The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014) -
An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
por: Kawalec, Paweł, et al.
Publicado: (2016)